Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Cancer Treatment Reviews|July 31, 2003
Thrombosis, prevalence and new evidence on current perceptions of riskHerbert M PinedoBioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 1, 2003
Making use of the primary tumourArnold Baars, Jan Buter, Herbert M PinedoNature Reviews. Cancer|May 25, 2007
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibitionHenk M W Verheul, Herbert M PinedoExpert Opinion on Emerging Drugs|June 7, 2005
Inhibition of angiogenesis in cancer patientsHenk M W Verheul, Herbert M PinedoDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 20, 2002
Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine)Andries M Bergman, Herbert M Pinedo, Godefridus J PetersBiochimica Et Biophysica Acta|August 21, 2003
Simulation model of doxorubicin activity in islets of human breast cancer cellsJan Lankelma, Rafael Fernández Luque, Henk Dekker, et al.Current Opinion in Oncology|May 25, 2006
On our way to targeted therapy for cachexia in cancer?Manon S A Boddaert, Winald R Gerritsen, Herbert M PinedoBiochemical Pharmacology|June 5, 2003
Cytosolic beta-glycosidases for activation of glycoside prodrugs of daunorubicinMichelle de Graaf, Herbert M Pinedo, Razi Quadir, et al.Current Pharmaceutical Design|June 8, 2002
Beta-glucuronidase-mediated drug releaseMichelle de Graaf, Epie Boven, Hans W Scheeren, et al.Biochemical Pharmacology|May 7, 2002
Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxelGeertruida M Kolfschoten, Theresia M Hulscher, Monique C A Duyndam, et al.Pageof 8